Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence has come to light revealing that the agency actually opposes the proposed rule it is supposed to defend and has engaged in improper communications with other … Continue reading New Evidence Shows DEA Opposes Marijuana Rescheduling And Should Be Removed From Hearings, Cannabis Groups Say